Retinoblastoma protein monoclonal antibodies with novel characteristics
Authors:
- Margarita NodelmanMNMargarita Nodelman
- Karen Nared-HoodKNKaren Nared-Hood
- John DuncanJDJohn Duncan
- Joseph GeradtsJGJoseph Geradts
- H.Michael ShepardHSH.Michael Shepard
- 10 March 1994
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 169 (2) , 231-240
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder CancerJNCI: Journal of the National Cancer Institute, 1992
- The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding proteinCell, 1991
- The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2FCell, 1991
- Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factorNature, 1991
- Altered Expression of the Retinoblastoma Gene Product in Human SarcomasNew England Journal of Medicine, 1990
- Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB GeneScience, 1990
- Point Mutational Inactivation of the Retinoblastoma AntioncogeneScience, 1989
- Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLCScience, 1988
- SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility geneCell, 1988
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcomaNature, 1986